Emanuella’s practice focuses on complex patent litigation involving pharmaceutical patents, encompassing invalidity and infringement actions, regulatory-driven disputes, and strategic expertise in patent prosecution.

Grounded in academic research across administrative, regulatory, and civil law - encompassing studies on pharmaceutical market regulation and digital markets - this background strengthens a litigation-oriented approach to disputes at the intersection of intellectual property, regulation, and market dynamics.

‍